Milestone Pharmaceuticals (MIST) Cash from Operations Growth (1y) (2019 - 2026)
Milestone Pharmaceuticals (MIST) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 158.60% |
| 10 | Milestone Pharmaceuticals | 148.53 Mn | -35.69 Mn | - | -15.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.06% |
| Dec 31, 2025 | -86.69% |
| Sep 30, 2025 | -38.90% |
| Jun 30, 2025 | -107.60% |
| Mar 31, 2025 | -56.17% |
| Dec 31, 2024 | 30.14% |
| Sep 30, 2024 | 42.29% |
| Jun 30, 2024 | 42.70% |
| Mar 31, 2024 | 35.75% |
| Dec 31, 2023 | 23.84% |
| Sep 30, 2023 | -5.07% |
| Jun 30, 2023 | 25.00% |
| Mar 31, 2023 | 0.32% |
| Dec 31, 2022 | -3.92% |
| Sep 30, 2022 | -23.22% |
| Jun 30, 2022 | -1,487.68% |
| Mar 31, 2022 | -11.86% |
| Dec 31, 2021 | -41.34% |
| Sep 30, 2021 | -28.06% |
| Jun 30, 2021 | 106.13% |